Vitro Biopharma(VTRO.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Vitro Biopharma
VTRO.US
Vitro Biopharma, Inc. develops and commercializes adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. Its products include cell culture media, cell lines, and nutravivo-dietary-supplements. The company was founded by James R. Musick on March 31, 1986 and is headquartered in Denver, CO.
--
VTRO.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Bora Biologics Celebrates Opening of $30 Million San Diego Manufacturing Expansion

    Bora Biologics has opened a $30 million expanded manufacturing facility in San Diego, enhancing its capabilities for 2,000 liter scale single-use biologics manufacturing. The expansion includes advanced GMP processing equipment and bioreactors, significantly increasing production capacity. CEO Stephen Lam emphasized the commitment to high-quality biologics and job creation in the region. San Diego Mayor Todd Gloria noted the importance of this investment for the local biotech ecosystem, highlighting its potential for economic growth and the production of life-saving medicines.

    Acceswire·
    Acceswire·
    © 2026 Longbridge｜Disclaimer